Johns Hopkins HIV Guide
Dapsone
INDICATIONS
FDA
FDA
- Leprosy
- Dermatitis herpetiformis
- Acne vulgaris (dapsone 5% gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- PCP prophylaxis
- Treatment of mild to moderately severe PCP (with trimethoprim)
- Toxoplasmosis prophylaxis (with pyrimethamine and leucovorin)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 5, 2017
Citation
Smith, Janessa, and Paul A Pham. "Dapsone." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545049/11/Dapsone.
Smith J, Pham PA. Dapsone. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545049/11/Dapsone. Accessed November 29, 2023.
Smith, J., & Pham, P. A. (2017). Dapsone. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545049/11/Dapsone
Smith J, Pham PA. Dapsone [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 November 29]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545049/11/Dapsone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dapsone
ID - 545049
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/07/05/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545049/11/Dapsone
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
